Trium Capital’s Theratechnologies THTX Stock Holding History
Bought
Maintained
Sold
Trium Capital's THTX Position: Q4 2025 in Review
Trium Capital sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 318,830 shares — an estimated $1.08M sold.
Trium Capital first reported a position in THTX in Q3 2025 and held it in 1 quarter. The position peaked at $1.08M in Q3 2025. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.
- Trium Capital reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
- Trium Capital sold 318,830 Theratechnologies shares in Q4 2025, an estimated $1.08M.
- Trium Capital first reported a position in Theratechnologies in Q3 2025 and held it in 1 quarter.
- Trium Capital's Theratechnologies position peaked at $1.08M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.
Based on Trium Capital's 13F filing for Q4 2025, filed 22 Jan 2026.